fingolimod hydrochloride has been researched along with Alveolar Soft Part Sarcoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kawai, A; Kondo, T; Kubota, D; Yoshida, A | 1 |
1 other study(ies) available for fingolimod hydrochloride and Alveolar Soft Part Sarcoma
Article | Year |
---|---|
Proteomics identified overexpression of SET oncogene product and possible therapeutic utility of protein phosphatase 2A in alveolar soft part sarcoma.
Topics: Adolescent; Adult; Apoptosis; Blotting, Western; Cell Movement; Cell Proliferation; DNA-Binding Proteins; Electrophoresis, Gel, Two-Dimensional; Enzyme Activators; Female; Fingolimod Hydrochloride; Histone Chaperones; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Proteins; Propylene Glycols; Protein Phosphatase 2; Proteome; Proteomics; RNA Interference; Sarcoma, Alveolar Soft Part; Sphingosine; Transcription Factors; Young Adult | 2014 |